These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 27389877)

  • 1. Receptor antagonism/agonism can be uncoupled from pharmacoperone activity.
    Janovick JA; Spicer TP; Smith E; Bannister TD; Kenakin T; Scampavia L; Conn PM
    Mol Cell Endocrinol; 2016 Oct; 434():176-85. PubMed ID: 27389877
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacoperone rescue of vasopressin 2 receptor mutants reveals unexpected constitutive activity and coupling bias.
    Janovick JA; Spicer TP; Bannister TD; Scampavia L; Conn PM
    PLoS One; 2017; 12(8):e0181830. PubMed ID: 28767678
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of Potential Pharmacoperones Capable of Rescuing the Functionality of Misfolded Vasopressin 2 Receptor Involved in Nephrogenic Diabetes Insipidus.
    Smith E; Janovick JA; Bannister TD; Shumate J; Scampavia L; Conn PM; Spicer TP
    J Biomol Screen; 2016 Sep; 21(8):824-31. PubMed ID: 27280550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-throughput screen for pharmacoperones of the vasopressin type 2 receptor.
    Conn PM; Smith E; Hodder P; Janovick JA; Smithson DC
    J Biomol Screen; 2013 Sep; 18(8):930-7. PubMed ID: 23640875
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemical validation and optimization of pharmacoperones targeting vasopressin type 2 receptor mutant.
    Janovick JA; Spicer TP; Bannister TD; Smith E; Ganapathy V; Scampavia L
    Biochem J; 2018 Sep; 475(18):2941-2953. PubMed ID: 30068530
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic rescue of misfolded/mistrafficked mutants: automation-friendly high-throughput assays for identification of pharmacoperone drugs of GPCRs.
    Smithson DC; Janovick JA; Conn PM
    Methods Enzymol; 2013; 521():3-16. PubMed ID: 23351731
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic rescue of misfolded mutants: validation of primary high throughput screens for identification of pharmacoperone drugs.
    Janovick JA; Park BS; Conn PM
    PLoS One; 2011; 6(7):e22784. PubMed ID: 21818389
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vasopressin receptors and pharmacological chaperones: from functional rescue to promising therapeutic strategies.
    Mouillac B; Mendre C
    Pharmacol Res; 2014 May; 83():74-8. PubMed ID: 24239889
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Misfolding of vasopressin receptors: biased agonist pharmacochaperones as potential therapeutics.
    Mendre C; Mouillac B
    Adv Protein Chem Struct Biol; 2019; 118():249-272. PubMed ID: 31928727
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of the V2 Vasopressin Receptor (V2R) Mutations Causing Partial Nephrogenic Diabetes Insipidus Highlights a Sustainable Signaling by a Non-peptide V2R Agonist.
    Makita N; Sato T; Yajima-Shoji Y; Sato J; Manaka K; Eda-Hashimoto M; Ootaki M; Matsumoto N; Nangaku M; Iiri T
    J Biol Chem; 2016 Oct; 291(43):22460-22471. PubMed ID: 27601473
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transitioning pharmacoperones to therapeutic use: in vivo proof-of-principle and design of high throughput screens.
    Conn PM; Smithson DC; Hodder PS; Stewart MD; Behringer RR; Smith E; Ulloa-Aguirre A; Janovick JA
    Pharmacol Res; 2014 May; 83():38-51. PubMed ID: 24373832
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological Chaperones as Potential Therapeutic Strategies for Misfolded Mutant Vasopressin Receptors.
    Mouillac B; Mendre C
    Handb Exp Pharmacol; 2018; 245():63-83. PubMed ID: 28939971
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutation in the V2 vasopressin receptor gene, AVPR2, causes nephrogenic syndrome of inappropriate diuresis.
    Erdélyi LS; Mann WA; Morris-Rosendahl DJ; Groß U; Nagel M; Várnai P; Balla A; Hunyady L
    Kidney Int; 2015 Nov; 88(5):1070-8. PubMed ID: 26131744
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular genetic study of congenital nephrogenic diabetes insipidus and rescue of mutant vasopressin V2 receptor by chemical chaperones.
    Cheong HI; Cho HY; Park HW; Ha IS; Choi Y
    Nephrology (Carlton); 2007 Apr; 12(2):113-7. PubMed ID: 17371330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological chaperoning: a primer on mechanism and pharmacology.
    Leidenheimer NJ; Ryder KG
    Pharmacol Res; 2014 May; 83():10-9. PubMed ID: 24530489
    [TBL] [Abstract][Full Text] [Related]  

  • 16. G protein-coupled receptor trafficking in health and disease: lessons learned to prepare for therapeutic mutant rescue in vivo.
    Conn PM; Ulloa-Aguirre A; Ito J; Janovick JA
    Pharmacol Rev; 2007 Sep; 59(3):225-50. PubMed ID: 17878512
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assay strategies for identification of therapeutic leads that target protein trafficking.
    Conn PM; Spicer TP; Scampavia L; Janovick JA
    Trends Pharmacol Sci; 2015 Aug; 36(8):498-505. PubMed ID: 26067100
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rescue of mutant gonadotropin-releasing hormone receptor function independent of cognate receptor activity.
    Smith E; Janovick JA; Bannister TD; Shumate J; Ganapathy V; Scampavia L; Spicer TP
    Sci Rep; 2020 Jun; 10(1):10579. PubMed ID: 32601341
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Three-Site Mechanism for Agonist/Antagonist Selective Binding to Vasopressin Receptors.
    Saleh N; Saladino G; Gervasio FL; Haensele E; Banting L; Whitley DC; Sopkova-de Oliveira Santos J; Bureau R; Clark T
    Angew Chem Int Ed Engl; 2016 Jul; 55(28):8008-12. PubMed ID: 27184628
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ligand recognition properties of the vasopressin V2 receptor studied under QSAR and molecular modeling strategies.
    Martínez-Archundia M; Colín-Astudillo B; Moreno-Vargas LM; Ramírez-Galicia G; Garduño-Juárez R; Deeb O; Contreras-Romo MC; Quintanar-Stephano A; Abarca-Rojano E; Correa-Basurto J
    Chem Biol Drug Des; 2017 Nov; 90(5):840-853. PubMed ID: 28419717
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.